180 related articles for article (PubMed ID: 20370321)
41. Analysis of protease activity in human otitis media.
Avidano MA; Cotter CS; Stringer SP; Schultz GS
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
[TBL] [Abstract][Full Text] [Related]
42. Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78.
Leidal KG; Munson KL; Johnson MC; Denning GM
J Interferon Cytokine Res; 2003 Jun; 23(6):307-18. PubMed ID: 12859857
[TBL] [Abstract][Full Text] [Related]
43. The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.
Caruso JA; Akli S; Pageon L; Hunt KK; Keyomarsi K
Oncogene; 2015 Jul; 34(27):3556-67. PubMed ID: 25195861
[TBL] [Abstract][Full Text] [Related]
44. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
45. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.
Morihara K; Tsuzuki H; Oda K
Infect Immun; 1979 Apr; 24(1):188-93. PubMed ID: 110691
[TBL] [Abstract][Full Text] [Related]
46. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
47. Novel role of the serine protease inhibitor elafin in gluten-related disorders.
Galipeau HJ; Wiepjes M; Motta JP; Schulz JD; Jury J; Natividad JM; Pinto-Sanchez I; Sinclair D; Rousset P; Martin-Rosique R; Bermudez-Humaran L; Leroux JC; Murray JA; Smecuol E; Bai JC; Vergnolle N; Langella P; Verdu EF
Am J Gastroenterol; 2014 May; 109(5):748-56. PubMed ID: 24710505
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic potential of human elafin.
Shaw L; Wiedow O
Biochem Soc Trans; 2011 Oct; 39(5):1450-4. PubMed ID: 21936832
[TBL] [Abstract][Full Text] [Related]
49. Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis.
Kamath S; Kapatral V; Chakrabarty AM
Mol Microbiol; 1998 Dec; 30(5):933-41. PubMed ID: 9988471
[TBL] [Abstract][Full Text] [Related]
50. Purification, biochemical and molecular characterization of a metalloprotease from Pseudomonas aeruginosa MN7 grown on shrimp wastes.
Jellouli K; Bayoudh A; Manni L; Agrebi R; Nasri M
Appl Microbiol Biotechnol; 2008 Jul; 79(6):989-99. PubMed ID: 18512057
[TBL] [Abstract][Full Text] [Related]
51. Reactions of the three AmpD enzymes of Pseudomonas aeruginosa.
Zhang W; Lee M; Hesek D; Lastochkin E; Boggess B; Mobashery S
J Am Chem Soc; 2013 Apr; 135(13):4950-3. PubMed ID: 23510438
[TBL] [Abstract][Full Text] [Related]
52. Alginate, the slime exopolysaccharide of Pseudomonas aeruginosa, binds human leukocyte elastase, retards inhibition by alpha 1-proteinase inhibitor, and accelerates inhibition by secretory leukoprotease inhibitor.
Ying QL; Kemme M; Simon SR
Am J Respir Cell Mol Biol; 1996 Aug; 15(2):283-91. PubMed ID: 8703486
[TBL] [Abstract][Full Text] [Related]
53. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
[TBL] [Abstract][Full Text] [Related]
54. Mechanistic insights into elastin degradation by pseudolysin, the major virulence factor of the opportunistic pathogen Pseudomonas aeruginosa.
Yang J; Zhao HL; Ran LY; Li CY; Zhang XY; Su HN; Shi M; Zhou BC; Chen XL; Zhang YZ
Sci Rep; 2015 Apr; 5():9936. PubMed ID: 25905792
[TBL] [Abstract][Full Text] [Related]
55. Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.
Olson JC; Ohman DE
J Bacteriol; 1992 Jun; 174(12):4140-7. PubMed ID: 1597429
[TBL] [Abstract][Full Text] [Related]
56. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides.
Zuyderduyn S; Ninaber DK; Schrumpf JA; van Sterkenburg MA; Verhoosel RM; Prins FA; van Wetering S; Rabe KF; Hiemstra PS
Respir Res; 2011 May; 12(1):59. PubMed ID: 21529380
[TBL] [Abstract][Full Text] [Related]
57. Modulation of the epithelial sodium channel (ENaC) by bacterial metalloproteases and protease inhibitors.
Butterworth MB; Zhang L; Liu X; Shanks RM; Thibodeau PH
PLoS One; 2014; 9(6):e100313. PubMed ID: 24963801
[TBL] [Abstract][Full Text] [Related]
58. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
Catanese J; Kress LF
Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
[TBL] [Abstract][Full Text] [Related]
60. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
Motta JP; Magne L; Descamps D; Rolland C; Squarzoni-Dale C; Rousset P; Martin L; Cenac N; Balloy V; Huerre M; Fröhlich LF; Jenne D; Wartelle J; Belaaouaj A; Mas E; Vinel JP; Alric L; Chignard M; Vergnolle N; Sallenave JM
Gastroenterology; 2011 Apr; 140(4):1272-82. PubMed ID: 21199654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
